| Curatis AG - Brinavess 500 mg, Konzentrat zur Herstellung einer Infusionslösung |
| 61304 | | 02 | | Brinavess 500 mg | | Konzentrat zur Herstellung einer Infusionslösung | | C01BG11 | | Vernakalant | | 16.03.2011 | | |
|
| Composition |
| vernakalanti hydrochloridum 500 mg corresp. vernakalantum 452.5 mg, acidum citricum monohydricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 25 ml corresp. natrium 78.75 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Vernakalanti Hydrochloridum | 500mg / 25ml correspond Vernakalantum 452.5mg / 25ml |
| | BAG: Active Agent | Dose |
|---|
| Vernakalanti Hydrochloridum | 500 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Sodium Chloride | | Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | Durchstechflasche(n) | 418.07 | 496.35 | B | | Yes |
|
